You are here: Industry Insights > New Drug

News List

UF researchers focus on new drug candidate Apratoxin S4 to treat vision loss pharmaceutical-technology
August 12, 2019
Researchers from the University of Florida (UF) College of Pharmacy have announced a partnership to focus on a new drug candidate Apratoxin S4 as a new method to prevent or treat vision loss.
Submission and acceptance of application for the production of new drug for Yisaipu(R)aqueous injection solution prnasia
August 06, 2019
3SBio Inc. (01530.HK), a leading biopharmaceutical company in the PRC, announces today that an application for the production of new drug has been submitted to the National Medical Products Administration for ...
New Drug for Diabetes-Induced Vision Loss TGA-Approved for Australian Patients prnasia
August 06, 2019
Australian patients with diabetes-induced eye disease can now access a new treatment option that provides consistent and continuous treatment with long-lasting effect.
FDA approves new drug to treat influenza fda
November 09, 2018
Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older
New drugs that have received conditional approval of marketing in China Erxiao
September 12, 2018
New drugs that have received conditional approval of marketing in China
“Conditional Approval” Contributing a Great Share in the New Drug Marketing Acceleration in China Erxiao
September 12, 2018
Several blockbuster drugs such as 9-valent HPV vaccine and Pyrotinib Maleate Tablets have recently been fast approved for marketing in China...
Amgen Submits Supplemental New Drug Application for Kyprolis americanpharmaceuticalreview
August 28, 2018
Amgen announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) to expand the Prescribing Information for Kyprolis (carfilzomib) to include a once-weekly dosing option in combination with dexamet
Breakthrough! Phase III Clinical Study of the Chinese New Drug for Alzheimer's Disease Met the Endpoint and is Waiting for Marketing Muzi
August 02, 2018
This can be called a “cardiac stimulant” to the AD drug market that has long been sluggish.
Promising new drug slows Parkinson's progression in mice pharmafile
July 06, 2018
According to investigators of the study, which has been published in the journal Nature Medicine, the compound prevents the process through which astrocytes – star shaped cells that assist neurons in communicating – are converted into aggressive ‘activat
Analysis of New Drug R&D Strategies: Advantages of First-to-Market Drugs Shrinking while Latecomer me-better Drugs Surpassing Mr. Nanguo
June 15, 2018
In the new drug development, pursuing the marketing of the first product of its variety is always the highest goal of pharmaceutical enterprises

Previous page 1 2 3 Next page